Archive: Discovery Epigenetics Drive Precision Medicine Approaches for Lymphoma
298 views · Published 2 October 2018 · 57:38 · Indexed 27 October 2026
Channel: UW Video · 2018 · Education
Epigenetic changes deregulate gene expression to drive carcinogenesis, but their reversible nature enables therapeutic targeting. Defining the epigenetic markers of lymphoma progression and drug resistance reveal new therapeutic opportunities, including novel targets and new combinations of existing drugs. This presentation will describe our work to map changes to the epigenetic landscape of B and T cell lymphomas and link them to cell survival, disease progression, and drug resistance. Ultimately, our goal is to identify novel therapeutic targets and to develop new approaches for lymphoma therapy. After viewing this lecture, participants should be able to: 1) Describe the techniques used to map and compare the epigenetic landscapes of neoplastic and normal cells. 2) Discuss how non-coding elements modulate gene expression. 3) Describe approaches for novel therapeutic targeting in lymphoma. Jacqueline Payton, MD, PhD Assistant Professor, Pathology & Immunology Medical Director, Molecular Diagnostics Laboratory Co-Director, Pathology Physician Scientist Training Program Washington University School of Medicine in St. Louis 9/26/18 http://depts.washington.edu/labweb/Education/ContEdu/ https://uw.edu/video
More from this channel
-
54:45
Archive: Usable Privacy and Security: Protecting People from Online Phishing Scams
-
58:27
Archive: Technology for Long-Term Care: Scaling Elder Care to the Next Billion
-
53:34
Archive: Closing the Innovation Gap
-
52:34
Archive: Hardness Amplification by Repetition
-
54:57
Archive: Network Coded Wireless Architecture
-
56:48
Archive: Computer Science Research for Global Development
-
58:16
Archive: Thinking Historically about Thinking Historically: Identity Politics to Ethical Action
-
27:18
Archive: Eastside Specialty Center: Coordination of Care